April 27, 2022
Webinars
Value-Based Care

Navigating Value-Based Care, Defining Value, and Drug Pricing Policy

Summary

Join Avalere for a live discussion on key trends in drug pricing, value, and regulatory shifts, and how these trends will impact manufacturers.

Following our annual Healthcare Industry Outlook webinar, we surveyed 1,400 healthcare stakeholders and found that life sciences companies are prioritizing 3 key initiatives moving into 2022:

Value-based approaches to care, including quality and performance management
Defining and demonstrating value of drugs
Legislative and regulatory efforts related to drug pricing

In our spring 2022 Life Sciences Perspective, Avalere experts took a deeper look into these topics and how they may impact your business as we move into Q2.

Downloads

Watch Here

Moderator

Moderator

Elizabeth Carpenter , President

As president of Avalere Health, Elizabeth Carpenter is responsible for the firm’s consulting, sales, and operational functions.

Panel 1: Value-based approaches to care including quality & performance management

Guest Speaker

Tricia Marine Barrett, MHSA Executive Director of Quality and Population Health Strategy, Bayer Pharmaceuticals

Panel 2: Approaches to defining & demonstrating value of drugs

Guest Speaker

Daniel C. Lane, PharmD, PhD, MBA Director, US Access Marketing-Customer & Portfolio Value Generation, Bristol Myers Squibb

Sarah Alwardt President
Advisory Services

Milena Sullivan Practice Director
Policy

Panel 3: Legislative & regulatory efforts related to drug pricing

Guest Speaker

Matt Kazan

Lance Grady Executive Vice President
Life Sciences Strategy & Growth

Downloads

Watch Here

From beginning to end, our team synergy
produces measurable results. Let's work together.